Simplicef: Product Information (Page 3 of 3)

EFFECTIVENESS

The clinical effectiveness of SIMPLICEF (cefpodoxime proxetil) was established in a multi-location (23 site) field study. In this study, 216 dogs with infected wounds or abscesses were treated with either SIMPLICEF (n=118) once daily at 5 mg/kg (2.3 mg/lb) body weight or with a active control antibiotic (n=98) administered twice daily for 5-7 days. In this study, SIMPLICEF was considered noninferior to the active control (88.7% versus 88.4% respectfully) in the treatment of canine skin infections (wounds and abscesses) caused by susceptible strains of Staphylococcus intermedius, Staphylococcus aureus, Streptococcus canis (group G, β hemolytic), Escherichia coli, Pasteurella multocida, and Proteus mirabilis.

ANIMAL SAFETY

In target animal safety studies, cefpodoxime was well tolerated at exaggerated daily oral doses of 100 mg/kg/day (10 times the maximum label dose) for 13 weeks in adult dogs and for 28 days in puppies (18- 23 days of age). Therefore, once daily administration of cefpodoxime oral tablets at the maximum labeled dose of 10 mg/kg for up to 28 days was shown to be safe in adult dogs and puppies.

Blood dyscrasia including neutropenias, may be seen following high doses of cephalosporins. Cephalosporin administration should be discontinued in such cases.

STORAGE INFORMATION

Store tablets at controlled room temperature 20° to 25°C (68° to 77°F). Dispense in tight, light-resistant container. Replace cap securely after each opening.

HOW SUPPLIED

SIMPLICEF tablets are available in the following strengths (cefpodoxime equivalent), colors, and sizes:
100 mg (reddish-orange, elliptical, scored, debossed with 5228)
Bottles of 100
Bottles of 250
200 mg (light orange, round rectangle, scored, debossed with 5229)
Bottles of 100
Bottles of 250

Approved by FDA under NADA # 141-232
zoetis
Manufactured by:
Sandoz
Kundl, Austria
Distributed by:
Zoetis Inc.
Kalamazoo, MI 49007
Revised: October 202046272333

PRINCIPAL DISPLAY PANEL — 100 mg 100 tabs Tablet Bottle Label

100 mg 100 tabs Tablet Bottle Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 100 mg 250 tabs Tablet Bottle Label

100 mg 250 tabs Tablet Bottle Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 200 mg 100 tabs Tablet Bottle Label

200 mg 100 tabs Tablet Bottle Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 200 mg 250 tabs Tablet Bottle Label

200 mg 250 tabs Tablet Bottle Label
(click image for full-size original)

SIMPLICEF cefpodoxime proxetil tablet
Product Information
Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:54771-5228
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CEFPODOXIME PROXETIL (CEFPODOXIME) CEFPODOXIME 100 mg
Product Characteristics
Color orange (reddish-orange) Score 2 pieces
Shape OVAL (elliptical) Size 11mm
Flavor Imprint Code 5228
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:54771-5228-1 100 TABLET in 1 BOTTLE None
2 NDC:54771-5228-2 250 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA141232 07/22/2004
SIMPLICEF cefpodoxime proxetil tablet
Product Information
Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:54771-5229
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CEFPODOXIME PROXETIL (CEFPODOXIME) CEFPODOXIME 200 mg
Product Characteristics
Color orange (reddish-orange) Score 2 pieces
Shape OVAL (elliptical) Size 15mm
Flavor Imprint Code 5228
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:54771-5229-1 100 TABLET in 1 BOTTLE None
2 NDC:54771-5229-2 250 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA141232 07/22/2004
Labeler — Zoetis Inc. (828851555)

Revised: 09/2022 Zoetis Inc.

Page 3 of 3 1 2 3

VetLabel.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VetLabel.com. Every individual animal healthcare product label entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Our database mirrors the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. VetLabel.com provides the full animal health subset of the FDA's repository. Veterinary information provided here is not intended as a substitute for direct consultation with a qualified veterinary professional.

Terms of Use | Copyright © 2022. All Rights Reserved.